Skip to main content
Equibles

Rock Springs Capital Management LP

Position in SGMT — Sagimet Biosciences Inc.

CIK 1595725 Baltimore, MD
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,932,500
-$635,754 QoQ
Shares Held
250,000
-68.3% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#35
of 122 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rock Springs Capital Management LP holds $1,502,002,537 across 70 Biotechnology names. SGMT ranks #60 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,105,210 $206,983,728
2 TVTX
Travere Therapeutics, Inc.
 2,179,069 $123,792,909
3 MDGL
Madrigal Pharmaceuticals, Inc.
 174,999 $93,965,713
4 MIRM
Mirum Pharmaceuticals, Inc.
 798,145 $93,438,835
5 RYTM
Rhythm Pharmaceuticals, Inc.
 692,598 $76,899,155
6 KYMR
Kymera Therapeutics, Inc.
 453,156 $51,963,398
7 ARGX
Argenx SE
 52,750 $48,939,867
8 ASND
Ascendis Pharma A/S
 168,750 $45,009,000

All Filings in SGMT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,932,500 250,000
2025-03-31 $2,568,254 787,808
2024-12-31 $3,545,136 787,808
2024-09-30 $2,182,228 787,808
2024-06-30 $2,694,303 787,808
2024-03-31 $4,177,036 770,671
2023-12-31 $4,001,884 738,355
2023-09-30 $6,497,524 738,355